TrialDiabetes, obesity & metabolism2019

A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).

David C Klonoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.